Natco Pharma

Natco Pharma Ltd Key Ratios

NSEBSE

₹881.65

(2.15%)

Jun 10, 2025|12:00:00 AM

Invest wise with Expert advice

QUICKLINKS FOR Natco Pharma Ltd

ConsolidatedStandalone

GraphTable

Y/e 31 Mar	Mar-2021	Mar-2020	Mar-2018	Mar-2017
Growth matrix (%)
Revenue growth	7.15	-12.34	8.14	93.82
Op profit growth	4.05	-37.24	35.85	157.3
EBIT growth	0.45	-34.61	40.39	186.49
Net profit growth	-4.31	-33.81	43.25	209.35
Profitability ratios (%)
OPM	29.54	30.42	42.49	33.82
EBIT margin	28.89	30.81	41.31	31.82
Net profit margin	21.48	24.06	31.86	24.05
RoCE	13.75	15.97	35.02	38.67
RoNW	2.79	3.36	7.37	8.25
RoA	2.55	3.11	6.75	7.3
Per share ratios (₹)
EPS	24.24	25.17	37.68	27.79
Dividend per share	5.25	6.75	8.25	6.75
Cash EPS	17.76	19.82	34.14	24.76
Book value per share	226.04	207.25	166.52	94.61
Valuation ratios
P/E	34.04	20.1	20.01	30.47
P/CEPS	46.43	25.52	22.08	34.2
P/B	3.65	2.44	4.52	8.95
EV/EBIDTA	21.17	13.71	14.35	21.43
Payout (%)
Dividend payout	25.81	27.64	21.86	24.19
Tax payout	-23.67	-19.44	-21.64	-22.34
Liquidity ratios
Debtor days	85.74	113.29	92.94	66.56
Inventory days	120.61	94.95	65.76	63.79
Creditor days	-60.19	-86.48	-96.47	-89.1
Leverage ratios
Interest coverage	-44.57	-27.45	-58.61	-34.75
Net debt / equity	0	0.06	0	0.11
Net debt / op. profit	-0.02	0.42	-0.01	0.27
Cost breakup (₹)
Material costs	-24.92	-19.92	-18.81	-29.65
Employee costs	-20.21	-19.58	-14.9	-12.03
Other costs	-25.32	-30.06	-23.78	-24.47